Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2)

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1387-1396

  Natsuaki, Masahiro ^a   Nakagawa, Yoshihisa ^b   Morimoto, Takeshi ^a   Ono, Koh ^a   Shizuta, Satoshi ^a   Furukawa, Yutaka ^c   Kadota, Kazushige ^d   Iwabuchi, Masashi ^e   Kato, Yoshihiro ^f   Suwa, Satoru ^g   Inada, Tsukasa ^h   Doi, Osamu ⁱ   Takizawa, Akinori ^j   Nobuyoshi, Masakiyo ^e   Kita, Toru ^c   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TENRI HOSPITAL   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

^e KOKURA MEMORIAL HOSPITAL   (Japan)

^f Saiseikai Noe Hospital   (Japan)

^g JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^h OSAKA RED CROSS HOSPITAL   (Japan)

ⁱ SHIZUOKA GENERAL HOSPITAL   (Japan)

^j SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRIC ACID DERIVATIVE; PROTON PUMP INHIBITOR; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863422041     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.350     Document Type: Article

References (23)

1. C. Indolfi, A. Cioppa, E. Stabile, E. Di Lorenzo, G. Esposito, A. Pisani, A. Leccia, L. Cavuto, A.M. Stingone, A. Chieffo, C. Capozzolo, M. Chiariello Effects of hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury J Am Coll Cardiol 35 2000 214 221
2. W.S. Weintraub, S.J. Boccuzzi, J.L. Klein, A.S. Kosinski, S.B. King III, R. Ivanhoe, J.C. Cedarholm, M.E. Stillabower, J.D. Talley, S.J. DeMaio, W.W. O'Neill, J.E. Frazier, C.L. Cohen-Bernstein, D.C. Robbins, C.L. Brown, R.W. Alexander Lack of effect of lovastatin on restenosis after coronary angioplasty Lovastatin Restenosis Trial Study Group N Engl J Med 331 1994 1331 1337
3. P.W. Serruys, D.P. Foley, G. Jackson, H. Bonnier, C. Macaya, M. Vrolix, A. Branzi, J. Shepherd, H. Suryapranata, P.J. de Feyter, R. Melkert, G.A. van Es, P.J. Pfister A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the Fluvastatin Angiographic Restenosis (FLARE) trial Eur Heart J 20 1999 58 69
4. G.S. Mintz, J.J. Popma, A.D. Pichard, K.M. Kent, L.F. Satler, C. Wong, M.K. Hong, J.A. Kovach, M.B. Leon Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study Circulation 94 1996 35 43
5. T. Kimura, S. Kaburagi, T. Tamura, H. Yokoi, Y. Nakagawa, N. Hamasaki, H. Nosaka, M. Nobuyoshi, G.S. Mintz, J.J. Popma, M.B. Leon Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy Circulation 96 1997 475 483
6. P.W. Serruys, P. de Feyter, C. Macaya, N. Kokott, J. Puel, M. Vrolix, A. Branzi, M.C. Bertolami, G. Jackson, B. Strauss, B. Meier Lescol Intervention Prevention Study (LIPS) Investigators Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial JAMA 287 2002 3215 3222
7. A.S. Petronio, G. Amoroso, U. Limbruno, B. Papini, M. De Carlo, A. Micheli, N. Ciabatti, M. Mariani Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound Am Heart J 149 2005 520 526
8. R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco, T. Motta, L. Mihalcsik, M. Tespili, O. Valsecchi, F.D. Kolodgie Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
9. S.H. Hofma, W.J. van der Giessen, B.M. van Dalen, P.A. Lemos, E.P. McFadden, G. Sianos, J.M. Ligthart, D. van Essen, P.J. de Feyter, P.W. Serruys Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation Eur Heart J 27 2006 166 170
10. Y. Nakagawa, T. Kimura, T. Morimoto, M. Nomura, K. Saku, S. Haruta, T. Muramatsu, M. Nobuyoshi, K. Kadota, H. Fujita, R. Tatami, N. Shiode, H. Nishikawa, Y. Shibata, S. Miyazaki, Y. Murata, T. Honda, T. Kawasaki, O. Doi, Y. Hiasa, Y. Hayashi, M. Matsuzaki, K. Mitsudo j-Cypher Registry Investigators Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) Am J Cardiol 106 2010 329 336
11. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, R.J. Glynn JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
12. H. Yasue, Y. Mizuno, E. Harada, T. Itoh, H. Nakagawa, M. Nakayama, H. Ogawa, S. Tayama, T. Honda, S. Hokimoto, S. Ohshima, Y. Hokamura, K. Kugiyama, M. Horie, M. Yoshimura, M. Harada, S. Uemura, Y. Saito SCAST (Statin and Coronary Artery Spasm Trial) Investigators Effects of a 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers J Am Coll Cardiol 51 2008 1742 1748
13. T. Kimura, T. Morimoto, Y. Furukawa, Y. Nakagawa, K. Kadota, M. Iwabuchi, S. Shizuta, H. Shiomi, T. Tada, J. Tazaki, Y. Kato, M. Hayano, M. Abe, T. Tamura, M. Shirotani, S. Miki, M. Matsuda, M. Takahashi, K. Ishii, M. Tanaka, T. Aoyama, O. Doi, R. Hattori, R. Tatami, S. Suwa, A. Takizawa, Y. Takatsu, M. Takahashi, H. Kato, T. Takeda, J.D. Lee, R. Nohara, H. Ogawa, C. Tei, M. Horie, H. Kambara, H. Fujiwara, K. Mitsudo, M. Nobuyoshi, T. Kita Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan Cardiovasc Interv Ther 26 2011 234 245
14. P.W. Serruys, A.T. Ong, L.A. van Herwerden, J.E. Sousa, A. Jatene, J.J. Bonnier, J.P. Schönberger, N. Buller, R. Bonser, C. Disco, B. Backx, P.G. Hugenholtz, B.G. Firth, F. Unger Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial J Am Coll Cardiol 46 2005 575 581
15. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
16. K. Goto, N. Shiode, K. Shirota, Y. Fukuda, F. Kitamura, K. Tominaga, Y. Kato, H. Miura, K. Inoue, M. Nobuyoshi Pathological finding of sirolimus-eluting stent (SES) restenosis lesion with black hole appearance on intravascular ultrasound Circ J 73 2009 1969 1971
17. Y. Otsuka, M. Nakamura, N. Kokubu, A. Tonooka, K. Inoue, T. Higami Diffuse in-stent restenosis of cypher stent due to hypersensitivity reaction confirmed by pathohistological findings Heart Vessels 27 2012 110 113
18. S. Abe, S. Yoneda, T. Kanaya, K. Oda, S. Nishino, M. Kageyama, I. Taguchi, N. Masawa, T. Inoue Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement Cardiovasc Pathol 21 2012 19 22
19. T. Inoue, M. Sata, Y. Hikichi, R. Sohma, D. Fukuda, T. Uchida, M. Shimizu, H. Komoda, K. Node Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis Circulation 115 2007 553 561
20. C. Rogers, S. Parikh, P. Seifert, E.R. Edelman Endogenous cell seeding Remnant endothelium after stenting enhances vascular repair Circulation 94 1996 2909 2914
21. G. Nakazawa, F. Otsuka, M. Nakano, M. Vorpahl, S.K. Yazdani, E. Ladich, F.D. Kolodgie, A.V. Finn, R. Virmani The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
22. K. Yamaji, T. Kimura, T. Morimoto, Y. Nakagawa, K. Inoue, Y. Soga, T. Arita, S. Shirai, K. Ando, K. Kondo, K. Sakai, M. Goya, M. Iwabuchi, H. Yokoi, H. Nosaka, M. Nobuyoshi Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation Circ Cardiovasc Interv 3 2010 468 475
23. Y. Oikawa, J. Yajima, M.A. Costa, S. Matsuno, M. Akabane, R. Funada, T. Inaba, Y. Nakagawa, M. Nakamura, K. Nagashima, H. Kirigaya, K. Ogasawara, H. Sawada, T. Aizawa Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential "thromborestenosis" phenomenon Eurointervention 6 2010 380 387